Chu X Y, Kato Y, Niinuma K, Sudo K I, Hakusui H, Sugiyama Y
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
J Pharmacol Exp Ther. 1997 Apr;281(1):304-14.
Irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11), is a potent anticancer drug that is increasingly used in chemotherapy. A frequent limiting side effect involves gastrointestinal toxicity (diarrhea), which is thought to be related to the biliary excretion of CPT-11 and its metabolites. Accordingly, the biliary excretion mechanisms for both the lactone and carboxylate forms of CPT-11 and its metabolites, SN-38 and its glucuronide (SN38-Glu), were investigated using Sprague-Dawley (SD) rats and Eisai hyperbilirubinemic rats (EHBR), with the latter being mutant rats with a genetic deficiency of the canalicular multispecific organic anion transporter. After i.v. administration of CPT-11, the biliary excretion clearance, defined as the biliary excretion rate normalized to the hepatic concentration, of both the lactone and carboxylate forms of SN38-Glu was much lower in EHBR. The biliary excretion clearance for the carboxylate form of both CPT-11 and SN-38 was also substantially smaller in EHBR and showed marked saturation with increasing dose only in SD rats. On the other hand, the biliary excretion clearance for the lactone forms of CPT-11 and SN-38 showed only a minimal difference in EHBR, compared with SD rats. These results suggest that, for the carboxylate form of CPT-11 and SN-38 and the carboxylate and lactone forms of SN38-Glu, there exists a specific transport system at the bile canalicular membrane that is deficient in EHBR. To confirm this hypothesis, the uptake of these substrates by isolated hepatic canalicular membrane vesicles (CMV) was examined. ATP-dependence was clearly observed for the uptake of these four compounds by CMV prepared from SD rats but not by CMV from EHBR. In addition, the compounds inhibited the ATP-dependent uptake of S-(2,4-dinitrophenyl) glutathione by CMV from SD rats, in a concentration-dependent manner. These results suggest that the biliary excretion of the carboxylate forms of CPT-11 and SN-38 and the carboxylate and lactone forms of SN38-Glu is mediated by the multispecific organic anion transporter, which is deficient in EHBR.
伊立替康,即7-乙基-10-[4-(1-哌啶基)-1-哌啶基]-羰基氧基喜树碱(CPT-11),是一种强效抗癌药物,在化疗中使用越来越广泛。一种常见的限制副作用是胃肠道毒性(腹泻),这被认为与CPT-11及其代谢产物的胆汁排泄有关。因此,使用斯普拉格-道利(SD)大鼠和卫材高胆红素血症大鼠(EHBR,后者是一种缺乏胆小管多特异性有机阴离子转运蛋白的突变大鼠)研究了CPT-11及其代谢产物SN-38及其葡萄糖醛酸苷(SN38-Glu)的内酯和羧酸盐形式的胆汁排泄机制。静脉注射CPT-11后,SN38-Glu的内酯和羧酸盐形式的胆汁排泄清除率(定义为胆汁排泄率相对于肝脏浓度的归一化值)在EHBR中要低得多。CPT-11和SN-38羧酸盐形式的胆汁排泄清除率在EHBR中也显著较小,并且仅在SD大鼠中随着剂量增加显示出明显的饱和现象。另一方面,与SD大鼠相比,CPT-11和SN-38内酯形式的胆汁排泄清除率在EHBR中仅显示出极小的差异。这些结果表明,对于CPT-11和SN-38的羧酸盐形式以及SN38-Glu的羧酸盐和内酯形式,在胆小管膜上存在一种特定的转运系统,而EHBR中缺乏该系统。为了证实这一假设,研究了分离的肝胆小管膜囊泡(CMV)对这些底物的摄取。从SD大鼠制备的CMV对这四种化合物的摄取明显观察到ATP依赖性,而从EHBR制备的CMV则没有。此外,这些化合物以浓度依赖性方式抑制了从SD大鼠制备的CMV对S-(2,4-二硝基苯基)谷胱甘肽的ATP依赖性摄取。这些结果表明,CPT-11和SN-38羧酸盐形式以及SN38-Glu羧酸盐和内酯形式的胆汁排泄是由多特异性有机阴离子转运蛋白介导的,而EHBR中缺乏该转运蛋白。